On the contrary, the use of TAK1 and RIPK1 kinase inhibitors in our in vitro experiments suggested that the lack of TAK1-mediated negative regulation on RIPK1 kinase activity was primarily responsible for PCD induction during ADM and likely prevented cancer development in KRASG12D TAK1ΔAC mice. The gene discussed is RIPK1; the disease is cancer.